Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $33.51 USD
Change Today -0.04 / -0.12%
Volume 453.8K
ZLTQ On Other Exchanges
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kristine N. Tatsutani Ph.D.

Former Chief Scientific Officer and Senior Vice President of Clinical, Regulatory & Quality, ZELTIQ Aesthetics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2013


Dr. Kristine N. Tatsutani, PhD served as the Chief Scientific Officer and Senior Vice President of Clinical, Regulatory & Quality at ZELTIQ Aesthetics from October 2012 to December 31, 2013 and also served as its Vice President of Enhanced Clinical Outcomes since July 2011. Dr. Tatsutani served as the Chief Technology Officer of Zeltiq Aesthetics Inc. since May 2011. She served as the Vice President of Clinical Affairs at Zeltiq Aesthetics Inc. since May 2011. She served ...

Read Full Background

Corporate Headquarters*

4698 Willow Road
Pleasanton, California 94588

United States

Phone: 925-474-2500
Fax: 925-474-2599

Board Members Memberships*

There is no Board Members Memberships data available.


University of California Berkeley
University of California Berkeley
University of California Berkeley

Other Affiliations*

Annual Compensation*

Total Annual Compensation$280,000

Stock Options*

All Other Compensation$174,402
Exercised Options76,630
Exercised Options Value$227,859
Exercisable Options39,919
Exercisable Options Value$479,077
Unexercisable Options59,626
Unexercisable Options Value$798,308
Total Value of Options$1,505,244
Total Number of Options176,175

Total Compensation*

Total Annual Cash Compensation$580,402
Total Short Term Compensation$280,000
Other Long Term Compensation$174,402
Total Calculated Compensation$580,402
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZLTQ:US $33.51 USD -0.04


Michael R. Davin Chairman and Chief Executive Officer
Cynosure, Inc.
Dolev Rafaeli Ph.D.Chief Executive Officer and Director
PhotoMedex, Inc.
Amit Meridor Chief Executive Officer and President
Syneron Medical Ltd.
Hae-Ryung Hwang Chief Executive Officer
Lutronic Corporation
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZELTIQ AESTHETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at